Pfizer Inc., headquartered in New York, USA, is one of the world’s leading biopharmaceutical companies. Established in 1849, Pfizer has played a pivotal role in advancing medical science, developing life-saving drugs, and improving global healthcare. Known for its groundbreaking research and development, Pfizer has been at the forefront of creating vaccines, therapies, and pharmaceutical solutions that address a wide range of diseases and medical conditions.
Pfizer’s commitment to innovation and patient-centric healthcare has led to numerous medical advancements, including its pivotal role in producing the COVID-19 vaccine in collaboration with BioNTech. Pfizer’s global reach, with products and services available in over 120 countries, highlights its dedication to improving healthcare outcomes worldwide. The company’s mission is to deliver breakthroughs that change patients’ lives, and it continues to focus on scientific excellence and global health improvements.
CEO and Founder of Pfizer
Pfizer was originally founded in 1849 by Charles Pfizer and Charles Erhart, two German immigrants who established the company in Brooklyn, New York. Over the years, Pfizer grew into a global pharmaceutical giant, expanding its research and development capabilities. Today, Pfizer is led by Dr. Albert Bourla, who took over as CEO in 2019. Under his leadership, Pfizer has made significant strides in healthcare innovation, particularly in its development of the COVID-19 vaccine. Albert Bourla has focused on driving Pfizer’s mission to become a science-driven organization, emphasizing research into cancer, cardiovascular diseases, immunology, and infectious diseases. His leadership has positioned Pfizer as a key player in addressing global health challenges.
List of Top Companies Under Pfizer (USA)
Pfizer has expanded its operations by acquiring several companies in the pharmaceutical and biotechnology sectors. These acquisitions have strengthened its research capabilities and expanded its portfolio of life-saving drugs and vaccines. Below is a list of top companies acquired or owned by Pfizer, along with their approximate valuations.
| Company Name | Year Acquired/Founded | Valuation | Industry |
|---|---|---|---|
| Wyeth | 2009 (Acquired) | $68 Billion | Biopharmaceuticals |
| Hospira | 2015 (Acquired) | $17 Billion | Injectable Drugs and Biosimilars |
| Array BioPharma | 2019 (Acquired) | $11.4 Billion | Cancer Therapies |
| King Pharmaceuticals | 2010 (Acquired) | $3.6 Billion | Pain Management Solutions |
| Medivation | 2016 (Acquired) | $14 Billion | Oncology Research |
| Anacor Pharmaceuticals | 2016 (Acquired) | $5.2 Billion | Dermatology and Anti-infective Drugs |
| Biohaven Pharmaceuticals | 2022 (Acquired) | $11.6 Billion | Migraine Therapies |
| Trillium Therapeutics | 2021 (Acquired) | $2.26 Billion | Cancer Immunotherapies |
| ReViral | 2022 (Acquired) | $525 Million | Respiratory Syncytial Virus (RSV) Therapies |
FAQs About Pfizer (USA)
Q1: When was Pfizer founded, and by whom?
A: Pfizer was founded in 1849 by Charles Pfizer and Charles Erhart in Brooklyn, New York.
Q2: Who is the current CEO of Pfizer?
A: Dr. Albert Bourla is the current CEO of Pfizer, having taken over in 2019. He has been instrumental in leading Pfizer’s COVID-19 vaccine efforts.
Q3: What is Pfizer best known for?
A: Pfizer is best known for its innovative pharmaceutical products, including the COVID-19 vaccine developed in partnership with BioNTech, as well as drugs for cardiovascular diseases, cancer, and other serious medical conditions.
Q4: What companies has Pfizer acquired?
A: Pfizer has acquired numerous companies, including Wyeth, Hospira, Array BioPharma, Medivation, and Biohaven Pharmaceuticals, to enhance its portfolio and research capabilities.
Q5: What is Pfizer’s market capitalization?
A: As of 2024, Pfizer’s market capitalization is approximately $220 billion, making it one of the largest pharmaceutical companies in the world.
Q6: What are Pfizer's key areas of focus in research?
A: Pfizer focuses on oncology, immunology, cardiovascular diseases, rare diseases, vaccines, and inflammation, with a strong emphasis on innovative therapies and life-saving treatments.
